Ascentage Pharma Group International (ASPHF)
USD 6.45
(10.73%)
USD 6.45
(10.73%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 726.29 Million CNY | 129.05% |
| 2022 | 317.08 Million CNY | 150.93% |
| 2021 | -622.59 Million CNY | -26.99% |
| 2020 | -490.28 Million CNY | 36.91% |
| 2019 | -777.1 Million CNY | 15.07% |
| 2018 | -915.04 Million CNY | -9121.45% |
| 2017 | -9.92 Million CNY | 96.62% |
| 2016 | -293.69 Million CNY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | 94.52 Million CNY | 10.92% |
| 2023 Q4 | 726.29 Million CNY | 4.96% |
| 2023 FY | 726.29 Million CNY | 129.05% |
| 2023 Q3 | 692 Million CNY | 632.07% |
| 2023 Q1 | 85.22 Million CNY | -73.12% |
| 2022 Q4 | 317.08 Million CNY | 8.44% |
| 2022 Q2 | -137.48 Million CNY | 8.65% |
| 2022 Q1 | -150.5 Million CNY | 75.83% |
| 2022 FY | 317.08 Million CNY | 150.93% |
| 2022 Q3 | 292.4 Million CNY | 312.68% |
| 2021 Q4 | -622.59 Million CNY | 6.96% |
| 2021 FY | -622.59 Million CNY | -26.99% |
| 2021 Q3 | -669.18 Million CNY | -53.62% |
| 2021 Q2 | -435.6 Million CNY | 2.17% |
| 2021 Q1 | -445.26 Million CNY | 9.18% |
| 2020 Q2 | -142.57 Million CNY | 4.34% |
| 2020 FY | -490.28 Million CNY | 36.91% |
| 2020 Q4 | -490.28 Million CNY | 2.04% |
| 2020 Q3 | -500.51 Million CNY | -251.07% |
| 2020 Q1 | -149.03 Million CNY | 80.82% |
| 2019 Q3 | -788.24 Million CNY | -23.01% |
| 2019 Q2 | -640.78 Million CNY | -136.04% |
| 2019 Q1 | 1.77 Billion CNY | 294.33% |
| 2019 FY | -777.1 Million CNY | 15.07% |
| 2019 Q4 | -777.1 Million CNY | 1.41% |
| 2018 Q3 | 1.15 Billion CNY | 0.0% |
| 2018 FY | -915.04 Million CNY | -9121.45% |
| 2018 Q4 | -915.04 Million CNY | -179.02% |
| 2018 Q1 | 399.15 Million CNY | 0.0% |
| 2017 FY | -9.92 Million CNY | 96.62% |
| 2016 FY | -293.69 Million CNY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Evofem Biosciences, Inc. | 42.79 Million USD | -1597.238% |
| Arch Therapeutics, Inc. | 5.64 Million USD | -12758.559% |
| CSL Limited | 10.52 Billion USD | 93.1% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 11620.283% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -114247.723% |
| BioStem Technologies, Inc. | 4.47 Million USD | -16140.993% |
| Capstone Therapeutics Corp. | 20.27 Million USD | -3482.063% |
| Qrons Inc. | 351.42 Thousand USD | -206571.371% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | 291061.862% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | -1572.19% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | -5571.291% |
| Skye Bioscience, Inc. | -5.72 Million USD | 12794.452% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | 3558993.571% |
| Rebus Holdings, Inc. | 305 Thousand USD | -238030.82% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | -3655706.111% |
| Burzynski Research Institute, Inc. | -1310.00 USD | 55442771.756% |
| Genscript Biotech Corporation | -1.06 Billion USD | 168.433% |
| Neon Bloom, Inc. | 622.36 Thousand USD | -116600.034% |
| Adynxx, Inc. | - USD | -Infinity% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | -4507.619% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | -17537.075% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | -180639.283% |
| SQZ Biotechnologies Company | -36.23 Million USD | 2104.247% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | -32291.772% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | -78233.689% |
| Mesoblast Limited | 55.85 Million USD | -1200.254% |
| Marizyme, Inc. | 18.56 Million USD | -3811.346% |
| Genus plc | 190.6 Million USD | -281.059% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | -32384.507% |
| Pharming Group N.V. | 109.8 Million USD | -561.45% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | -84329.712% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | -59732.456% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | -106708.676% |
| ContraFect Corporation | -6.02 Million USD | 12152.755% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | -539341.767% |
| Sienna Biopharmaceuticals, Inc. | - USD | -Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | -62759.682% |
| IMV Inc. | 7.67 Million USD | -9368.705% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | -13100.886% |
| MultiCell Technologies, Inc. | 90.04 USD | -806640282.052% |
| ONE Bio Corp. | 9.04 Million USD | -7934.25% |
| Accustem Sciences Inc. | -733.97 Thousand USD | 99053.783% |
| RVL Pharmaceuticals plc | 12.94 Million USD | -5510.219% |
| Arno Therapeutics, Inc. | - USD | -Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | -52993.158% |
| Q BioMed Inc. | 4.06 Million USD | -17789.103% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | -2277.1% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | -71973.779% |
| Biomind Labs Inc. | 711.4 Thousand USD | -101994.034% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | -1099.587% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | -36225.993% |
| TetraLogic Pharmaceuticals Corporation | - USD | -Infinity% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | -201812.374% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | -519412.317% |
| Curative Biotechnology, Inc. | 2.2 Million USD | -32883.89% |
| GB Sciences, Inc. | 1.74 Million USD | -41466.551% |
| Alpha Cognition Inc. | -183.78 Thousand USD | 395283.037% |
| HST Global, Inc. | 96.79 Thousand USD | -750263.146% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | -352101.322% |
| Halberd Corporation | 144.72 Thousand USD | -501761.513% |
| Enzolytics Inc. | 981.65 Thousand USD | -73887.12% |
| Agentix Corp. | 37.63 Thousand USD | -1929955.008% |
| Resverlogix Corp. | 6.45 Million USD | -11158.704% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | 108005.344% |
| MetaStat, Inc. | - USD | -Infinity% |
| argenx SE | -2.02 Billion USD | 135.799% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 1644.923% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | -10171.558% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | -26714.405% |
| GeneThera, Inc. | - USD | -Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 8316.134% |
| AVAX Technologies, Inc. | -5.9 Million USD | 12403.465% |
| Zenith Capital Corp. | 10.06 Thousand USD | -7216702.464% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | -362266.788% |
| Anthera Pharmaceuticals, Inc. | - USD | -Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | -30339.591% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | -441394.994% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | 3965047.047% |
| Kadimastem Ltd | -253.1 Thousand USD | 287059.013% |
| Helix BioMedix, Inc. | -2.57 Million USD | 28360.31% |
| VitaSpring Biomedical Co. Ltd. | - USD | -Infinity% |
| Oncology Pharma Inc. | - USD | -Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | -360786.74% |
| LadRx Corporation | -2.03 Million USD | 35764.623% |
| Cell Source, Inc. | 9.23 Million USD | -7767.215% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | -114247.723% |
| NovAccess Global Inc. | 2.17 Million USD | -33239.943% |
| Affymax, Inc. | -5.59 Million USD | 13076.577% |
| Itoco Inc. | 228.3 Thousand USD | -318026.629% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | -533986.581% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | -14551.987% |
| Mobile Lads Corp. | 484.23 Thousand USD | -149889.881% |
| CytoDyn Inc. | 20.26 Million USD | -3484.538% |
| Claritas Pharmaceuticals, Inc. | - USD | -Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | 112256514.219% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | 7836443.941% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | -9325.108% |
| SYBLEU INC | 473.71 Thousand USD | -153220.147% |
| Advanced Proteome Therapeutics Corporation | - USD | -Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | -16195.612% |
| International Stem Cell Corporation | 2.59 Million USD | -27942.432% |
| Bioxytran, Inc. | 1.89 Million USD | -38148.125% |
| GlobeImmune, Inc. | - USD | -Infinity% |
| Predictive Technology Group, Inc. | - USD | -Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | -1163598.268% |
| Cardax, Inc. | - USD | -Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | -33202.719% |
| Kaleido Biosciences, Inc. | - USD | -Infinity% |
| Advaxis, Inc. | 3.43 Million USD | -21050.233% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | -8391.746% |
| RenovaCare, Inc. | - USD | -Infinity% |
| Regnum Corp. | 772.6 Thousand USD | -93906.267% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | 58203.92% |
| Neutra Corp. | 52.18 Thousand USD | -1391623.993% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | 29280.354% |
| PureTech Health plc | -167.19 Million USD | 534.397% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | 296659.933% |
| IXICO plc | -4.44 Million USD | 16441.203% |
| IntelGenx Technologies Corp. | 13.21 Million USD | -5394.357% |
| Gelesis Holdings, Inc. | 54.85 Million USD | -1224.131% |
| CSL Limited | 10.52 Billion USD | 93.1% |
| Cellectis S.A. | -43.81 Million USD | 1757.503% |